12-week Open-label Evaluation of Efficacy and Safety of Indacaterol

Summary

In this 12-week study, patients were randomized to either open-label indacaterol or standard of care for Chronic Obstructive Pulmonary Disease (COPD) treatment; efficacy and safety were assessed.

Timeline

Start

2011-03

Primary completion

2012-05

Completion

2012-05

Drugs

Indications